Literature DB >> 1627297

Demonstration of interleukin 6 in middle ear effusions.

R F Yellon1, G Leonard, P Marucha, J Sidman, R Carpenter, J Burleson, J Carlson, D Kreutzer.   

Abstract

In response to infection in the middle ear, inflammatory cells produce cytokines--potent regulators and mediators of the immune response. In an earlier study, we demonstrated that levels of the cytokine interleukin 1 were higher in middle-ear effusions from younger children, while levels of the cytokine tumor necrosis factor were higher in middle-ear effusions from older children and in those requiring tympanostomy on multiple occasions. In this study, we evaluated middle-ear effusions for levels of the cytokine interleukin 6. Activities of interleukin 6 include stimulation of bone erosion and production of antibodies and fever. Using an enzyme-linked immunosorbent assay system, significant levels of interleukin 6 (greater than 0.2 pg/mL) were found in 14 (36%) of 39 middle-ear effusions from 25 children with otitis media with effusion. The mean (+/- SE) level of interleukin 6 in middle-ear effusions was 173.9 +/- 74.7 pg/mg of total protein. Like interleukin 1, levels of interleukin 6 were higher in younger children. Tumor necrosis factor may be an important regulator of the local immune response in the middle-ear cleft during persistence of otitis media with effusion, while interleukin 1 and interleukin 6 may be important regulators during the early stages of otitis media with effusion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627297     DOI: 10.1001/archotol.1992.01880070075014

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  8 in total

1.  Effects of Allergina on the treatment of otitis media with effusions.

Authors:  Hyun-Ja Jeong; Seung-Heon Hong; Sung-Chul Kim; Eun-Jeong Park; Chul-Ho Jang; Kyung-Suk Kim; Hyung-Min Kim
Journal:  Inflammation       Date:  2002-04       Impact factor: 4.092

2.  Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.

Authors:  J Bujía; C Kim; P Ostos; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

3.  Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model.

Authors:  K Sato; C L Liebeler; M K Quartey; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Pro-inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion.

Authors:  Beata Zielnik-Jurkiewicz; Wanda Stankiewicz-Szymczak
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-16       Impact factor: 2.503

5.  Cigarette smoke activates NFκB-mediated Tnf-α release from mouse middle ear cells.

Authors:  Diego Preciado; Elaine Kuo; Samaneh Ashktorab; Peter Manes; Mary Rose
Journal:  Laryngoscope       Date:  2010-12       Impact factor: 3.325

6.  Role of macrophage migration inhibitory factor in otitis media with effusion in adults.

Authors:  Shin Kariya; Mitsuhiro Okano; Katsuya Aoji; Michiya Kosaka; Emiko Chikumoto; Hisashi Hattori; Koji Yuen; Shinji Nishioka; Keiko Nishioka; Kazunori Nishizaki
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

7.  Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model.

Authors:  K Sato; M K Quartey; C L Liebeler; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

8.  Effect of Ginkgo leaf parenteral solution on blood and cochlea antioxidant and immunity indexes in OM rats.

Authors:  Jiandong Zhao; Yu Su; Aiting Chen; Hu Yuan; Liangfa Liu; Wenming Wu
Journal:  Molecules       Date:  2011-12-15       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.